A detailed history of Nisa Investment Advisors, LLC transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 380 shares of ATOS stock, worth $463. This represents 0.0% of its overall portfolio holdings.

Number of Shares
380
Holding current value
$463
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$1.09 - $1.52 $414 - $577
380 New
380 $0
Q2 2022

Aug 03, 2022

SELL
$0.85 - $1.28 $7,055 - $10,624
-8,300 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$1.11 - $1.74 $9,213 - $14,442
8,300 New
8,300 $10,000

Others Institutions Holding ATOS

About ATOSSA THERAPEUTICS, INC.


  • Ticker ATOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,624,000
  • Market Cap $154M
  • Description
  • Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...
More about ATOS
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.